Vascular Pharmacology

1.8k papers and 44.5k indexed citations i.

About

The 1.8k papers published in Vascular Pharmacology in the last decades have received a total of 44.5k indexed citations. Papers published in Vascular Pharmacology usually cover Molecular Biology (650 papers), Cardiology and Cardiovascular Medicine (496 papers) and Physiology (420 papers) specifically the topics of Nitric Oxide and Endothelin Effects (331 papers), Renin-Angiotensin System Studies (123 papers) and Eicosanoids and Hypertension Pharmacology (119 papers). The most active scholars publishing in Vascular Pharmacology are Raffaele De Caterina, Rosalinda Madonna, Stephen M. Black, John D. Catravas and Lusiane Maria Bendhack.

In The Last Decade

Fields of papers published in Vascular Pharmacology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Vascular Pharmacology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Vascular Pharmacology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Vascular Pharmacology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Vascular Pharmacology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025